Lanreotide (Somatuline Autogel) in Thyroid-associated Ophthalmopathy Treatment

Clinical trial NCT00288522 · TERMINATED

Trial details

NCT number: NCT00288522
Sponsor: Ipsen
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Thyroid-Associated Ophthalmopathy

Start date: 2006-01-01
Primary completion: 2007-04-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.